# Curai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curai

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.curai.com
- Total disclosed funding: $39M
- Latest round: Series B (Oct 16, 2020)
- Investors on record: 3

## About

Curai, Inc. is a healthcare technology company that utilizes artificial intelligence to transform primary care delivery, focusing on enhancing patient experiences through a robust virtual care platform.Curai, Inc., founded in 2017, is based in San Francisco, US. The company specializes in providing a reengineered model of primary care using AI technology. Neal Khosla is both the Founder and CEO of Curai. The company has successfully raised funds through 3 deals, with the latest being a Series B round in October 2020, where it secured USD 28.5 mn led by 5Y Capital and joined by General Catalyst Partners and Khosla Ventures. The total amount raised by Curai to date is USD 28.5 mn and the current company valuation stands at USD 117.217 mn.Curai specializes in delivering a reengineered model of primary care leveraging artificial intelligence (AI). Their core offerings include a comprehensive virtual care platform that enhances patient experience, expands access, and promotes continuous care relationships. This platform allows healthcare providers to deliver services at an individualized pace determined by the patient, effectively addressing high-volume care demands while minimizing physician burnout. Curai's solutions are designed to serve a diverse client base, including health plans, third-party administrators (TPAs), and employers, facilitating the delivery of scalable and cost-optimized healthcare services. The company operates primarily in North America, focusing on broadening access to essential health services for various population demographics, thereby promoting improved health outcomes and equity in care.Curai's revenue model is structured around B2B partnerships with health plans, TPAs, and employers, enabling these organizations to integrate Curai's virtual care services into their health offerings. The transactions typically involve subscription-based agreements, allowing clients to access Curai's comprehensive healthcare tools and technology. This subscription model is designed to provide continuous, scalable support for virtual primary care delivery, enhancing overall patient engagement and satisfaction. Pricing structures are tailored to meet the specific needs of each client, taking into consideration the size and scope of their health service offerings. Curai’s flagship products are focused on utilizing AI to streamline care delivery, optimize workflow, and ultimately reduce costs associated with traditional healthcare models.In October 2020, Curai, Inc. raised USD 28.5 mn in Series B funding, aimed at enhancing its product offerings and market reach. The company plans to develop new features for its virtual care platform to improve patient engagement and streamline care delivery. Additionally, Curai is targeting expansion into new markets, including Europe and Asia, by 2023, leveraging the recent funding to increase operational capabilities and reach a broader audience.

## Funding rounds

- Series B, Oct 16, 2020, $29M — General Catalyst Partners, Khosla Ventures, 5Y Capital
- Series A, May 29, 2018, $0.7M — General Catalyst Partners, Khosla Ventures
- Series A, Feb 28, 2018, $10M — General Catalyst Partners, Khosla Ventures

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series A, Series B
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A, Series B
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series B